Derivatives of C2-symmetrical bivalent phenylboronic acid exhibit several remarkable biological activities such as anti-herpes simplex virus (HSV)-1 and cytotoxic activities against Vero cells and they can reverse the effect of anticancer drugs. Novel symmetrical bivalent molecules were synthesized and their biological activities were evaluated in vitro using a human brain glioma cell line (U251) and a human carcinoma cell line (KB3-1). Among the tested compounds (1a–i), bivalent C2-symmetrical phenylboronic acid derivative 1g showed the highest anti-proliferative activity towards both U251 and KB3-1 cells. The values of 50% anti-proliferative activity (IC50) of this compound against the two cell lines (U251 and KB3-1) were 19.0 and 3.78 µM, respectively. The anti-proliferative activity of compound 1g towards KB3-1 cells was higher than that of cisplatin. The bivalent C2-symmetrical compound 1g had a linear methylene linker in the molecule.
C2对称二价苯
硼酸衍
生物具有多种显著的
生物活性,例如抗单纯疱疹病毒(HSV)-1和针对Vero细胞的细胞毒性,它们可以逆转抗癌药物的作用。研究人员合成了新型对称二价分子,并使用人脑胶质瘤
细胞系(U251)和人癌
细胞系(KB3-1)对其
生物活性进行了体外评估。在测试的化合物(1a-i)中,二价C2对称苯
硼酸衍
生物1g对U251和KB3-1细胞具有最高的抗增殖活性。该化合物对两种
细胞系(U251和KB3-1)的50%抗增殖活性(IC50)值分别为19.0和3.78微摩尔。化合物1g对KB3-1细胞的抗增殖活性高于
顺铂。二价C2对称化合物1g在分子中具有线性亚甲基连接。